272 related articles for article (PubMed ID: 29066510)
1. Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition.
Li Y; Zhong C; Liu D; Yu W; Chen W; Wang Y; Shi S; Yuan Y
Cancer Res; 2018 Jan; 78(1):230-245. PubMed ID: 29066510
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's sarcoma-associated herpesvirus vFLIP promotes MEndT to generate hybrid M/E state for tumorigenesis.
Chen W; Ding Y; Liu D; Lu Z; Wang Y; Yuan Y
PLoS Pathog; 2021 Dec; 17(12):e1009600. PubMed ID: 34936683
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus promotes mesenchymal-to-endothelial transition by resolving the bivalent chromatin of PROX1 gene.
Ding Y; Chen W; Lu Z; Wang Y; Yuan Y
PLoS Pathog; 2021 Sep; 17(9):e1009847. PubMed ID: 34492084
[TBL] [Abstract][Full Text] [Related]
4. Unveiling the role of KSHV-infected human mesenchymal stem cells in Kaposi's sarcoma initiation.
Lacunza E; Ahuja A; Coso OA; Abba M; Ramos JC; Cesarman E; Mesri EA; Naipauer J
J Med Virol; 2024 May; 96(5):e29684. PubMed ID: 38773828
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic analysis of KSHV-infected primary oral fibroblasts: The role of interferon-induced genes in the latency of oncogenic virus.
Dai L; Bai L; Lin Z; Qiao J; Yang L; Flemington EK; Zabaleta J; Qin Z
Oncotarget; 2016 Jul; 7(30):47052-47060. PubMed ID: 27363016
[TBL] [Abstract][Full Text] [Related]
6. KSHV enhances mesenchymal stem cell homing and promotes KS-like pathogenesis.
Wang X; Chen W; Yuan Y
Virology; 2020 Oct; 549():5-12. PubMed ID: 32777727
[TBL] [Abstract][Full Text] [Related]
7. Human Mesenchymal Stem Cells of Diverse Origins Support Persistent Infection with Kaposi's Sarcoma-Associated Herpesvirus and Manifest Distinct Angiogenic, Invasive, and Transforming Phenotypes.
Lee MS; Yuan H; Jeon H; Zhu Y; Yoo S; Shi S; Krueger B; Renne R; Lu C; Jung JU; Gao SJ
mBio; 2016 Jan; 7(1):e02109-15. PubMed ID: 26814175
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.
McAllister SC; Moses AV
Curr Top Microbiol Immunol; 2007; 312():211-44. PubMed ID: 17089799
[TBL] [Abstract][Full Text] [Related]
9. PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment.
Naipauer J; Rosario S; Gupta S; Premer C; Méndez-Solís O; Schlesinger M; Ponzinibbio V; Jain V; Gay L; Renne R; Chan HL; Morey L; Salyakina D; Abba M; Williams S; Hare JM; Goldschmidt-Clermont PJ; Mesri EA
PLoS Pathog; 2019 Dec; 15(12):e1008221. PubMed ID: 31881074
[TBL] [Abstract][Full Text] [Related]
10. The Kaposi's sarcoma progenitor enigma: KSHV-induced MEndT-EndMT axis.
Naipauer J; Mesri EA
Trends Mol Med; 2023 Mar; 29(3):188-200. PubMed ID: 36635149
[TBL] [Abstract][Full Text] [Related]
11. KSHV-initiated notch activation leads to membrane-type-1 matrix metalloproteinase-dependent lymphatic endothelial-to-mesenchymal transition.
Cheng F; Pekkonen P; Laurinavicius S; Sugiyama N; Henderson S; Günther T; Rantanen V; Kaivanto E; Aavikko M; Sarek G; Hautaniemi S; Biberfeld P; Aaltonen L; Grundhoff A; Boshoff C; Alitalo K; Lehti K; Ojala PM
Cell Host Microbe; 2011 Dec; 10(6):577-90. PubMed ID: 22177562
[TBL] [Abstract][Full Text] [Related]
12. Kaposi Sarcoma-Associated Herpesvirus and Staphylococcus aureus Coinfection in Oral Cavities of HIV-Positive Patients: A Unique Niche for Oncogenic Virus Lytic Reactivation.
Dai L; Qiao J; Yin J; Goldstein A; Lin HY; Post SR; Qin Z
J Infect Dis; 2020 Mar; 221(8):1331-1341. PubMed ID: 31111897
[TBL] [Abstract][Full Text] [Related]
13. Kaposi sarcoma herpesvirus promotes endothelial-to-mesenchymal transition through Notch-dependent signaling.
Gasperini P; Espigol-Frigole G; McCormick PJ; Salvucci O; Maric D; Uldrick TS; Polizzotto MN; Yarchoan R; Tosato G
Cancer Res; 2012 Mar; 72(5):1157-69. PubMed ID: 22237624
[TBL] [Abstract][Full Text] [Related]
14. The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma.
Gramolelli S; Schulz TF
J Pathol; 2015 Jan; 235(2):368-80. PubMed ID: 25212381
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of human fetal mesenchymal stem cells to Kaposi sarcoma-associated herpesvirus.
Parsons CH; Szomju B; Kedes DH
Blood; 2004 Nov; 104(9):2736-8. PubMed ID: 15238422
[TBL] [Abstract][Full Text] [Related]
16. Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells.
McAllister SC; Hansen SG; Ruhl RA; Raggo CM; DeFilippis VR; Greenspan D; Früh K; Moses AV
Blood; 2004 May; 103(9):3465-73. PubMed ID: 14726403
[TBL] [Abstract][Full Text] [Related]
17. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
[TBL] [Abstract][Full Text] [Related]
18. Mast Cell Activation and KSHV Infection in Kaposi Sarcoma.
Ayers LW; Barbachano-Guerrero A; McAllister SC; Ritchie JA; Asiago-Reddy E; Bartlett LC; Cesarman E; Wang D; Rochford R; Martin JN; King CA
Clin Cancer Res; 2018 Oct; 24(20):5085-5097. PubMed ID: 30084838
[No Abstract] [Full Text] [Related]
19. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.
Ganem D
J Clin Invest; 2010 Apr; 120(4):939-49. PubMed ID: 20364091
[TBL] [Abstract][Full Text] [Related]
20. Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma.
Marcelin AG; Gorin I; Morand P; Ait-Arkoub Z; Deleuze J; Morini JP; Calvez V; Dupin N
AIDS Res Hum Retroviruses; 2004 Jul; 20(7):704-8. PubMed ID: 15307914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
